🔍

Pee Cee Cosma Sope Ltd (524136)

📊 BSE: 524136 🏢 Household Products 📢 Latest filing: 12 Aug 2026

Latest quarterly results (Q1 FY27)

In its latest reported quarter, Q1 FY27, Pee Cee's revenue was ₹49.3 Cr (+23.4% year on year, +13.7% on the previous quarter), and net profit ₹3.3 Cr (+11.8% year on year); the operating margin was 7.5%.

Q1 FY27 (₹ Cr)	Value	YoY vs Q1 FY26	QoQ
Revenue	₹49.3	+23.4%	+13.7%
Operating profit	₹3.7	+5.5%	+15.7%
Net profit	₹3.3	+11.8%	+242.4%
EPS (₹)	12.30	+11.8%	+242.6%
Operating margin	7.5%	—	—

Full quarterly financials → Results calendar →

📢 Recent Corporate Announcements

Rs 3.25 Cr PAT: Pee Cee Cosma Sope Reports 12% YoY Profit Growth and Segment Diversification

🟢 POSITIVE ⭐ 7/10

EARNINGS 📅 12 Aug 2026, 06:06 PM

Pee Cee Cosma Sope reported a 23.3% YoY increase in consolidated revenue to Rs 49.28 Cr for Q1 FY27. Consolidated Net Profit grew 11.7% YoY to Rs 3.25 Cr, showing a sharp recovery from the Rs 0.95 Cr reported in the preceding quarter (Q4 FY26). Notably, the company has operationalized new segments, with Nutraceutical Ingredients contributing Rs 1.62 Cr to the top line. The core Laundry Soap and Detergent segment remains the primary driver, contributing Rs 48.66 Cr to standalone revenue.

Consolidated Revenue from Operations grew 23.3% YoY to Rs 49.28 Cr from Rs 39.95 Cr.
Consolidated Net Profit increased to Rs 3.25 Cr, up 11.7% from Rs 2.91 Cr in the year-ago quarter.
New Nutraceutical Ingredients segment generated Rs 1.62 Cr in its first reported quarter.
Earnings Per Share (EPS) improved to Rs 12.30 from Rs 11.00 YoY.
Cost of Materials Consumed rose significantly to Rs 37.86 Cr compared to Rs 28.93 Cr YoY, impacting gross margins.

💡 Investors should monitor the scale-up and profitability of the new Nutraceutical and Infrastructure segments, as the core detergent business remains sensitive to raw material price volatility.

Pee Cee Cosma Sope Q1 PAT up 12% to Rs 3.35 Cr; Rs 10 Cr investment in subsidiaries approved

🟢 POSITIVE ⭐ 7/10

EARNINGS 📅 12 Aug 2026, 05:53 PM

Pee Cee Cosma Sope reported a strong start to FY27 with Q1 revenue growing 19.1% YoY to Rs 47.43 Cr. Net profit increased 12.3% YoY to Rs 3.35 Cr, while operating margins remained stable. Significantly, the board approved a total capital infusion of Rs 10 Cr into two wholly-owned subsidiaries (Rs 5 Cr each) to fund expansion into Energy, Reality, and Nutraceuticals. This investment is material, representing approximately 17.8% of the company's current net worth of Rs 56 Cr.

Revenue from operations increased to Rs 47.43 Cr in Q1 FY27 from Rs 39.81 Cr in Q1 FY26.
Net Profit for the quarter stood at Rs 3.35 Cr, up from Rs 2.99 Cr in the corresponding previous quarter.
Approved Rs 5 Cr investment in Pee Cee Energy and Reality Ltd for working capital and business expansion.
Approved Rs 5 Cr investment in Abhaya Nourishtech Ltd, targeting the milk/plant protein and nutraceuticals market.
The 39th Annual General Meeting (AGM) is scheduled for September 29, 2026.

💡 Investors should monitor the execution and gestation period of the new investments in Energy and Nutraceuticals, as these represent a significant diversification from the core soap business. Watch for further details on the non-compete agreement involving India Trading Infra Ltd during the upcoming AGM.

Rs 5 Cr investment approved for wholly-owned subsidiary India Trading Infra Ltd

🟡 NEUTRAL ⭐ 5/10

EXPANSION 📅 11 Aug 2026, 01:43 PM

Pee Cee Cosma Sope Ltd has approved a capital infusion of up to Rs 5 crore into its wholly-owned subsidiary, India Trading Infra Ltd. The investment will be executed through a rights issue of 50,00,000 equity shares at a face value of Rs 10 each. This investment represents approximately 8.9% of the company's current net worth of Rs 56 crore. The funds are earmarked for addressing working capital needs and supporting the expansion of the subsidiary's infrastructure materials trading business.

Investment of up to Rs 5,00,00,000 (Rs 5 crore) in equity shares approved by the Executive Committee.
Subscription involves up to 50,00,000 equity shares at a par value of Rs 10 per share.
Target subsidiary, India Trading Infra Ltd, reported a small turnover of Rs 23.00 lacs.
Capital infusion represents ~8.9% of the parent company's net worth (Rs 56 Cr) and ~4.9% of its market cap (Rs 102 Cr).
Funds intended for general business requirements, working capital, and expansion activities.

💡 Investors should monitor the subsidiary's performance in future quarters to see if this capital infusion leads to a meaningful increase in its currently low turnover of Rs 23 lacs.

Aug 12 Board Meeting to Consider Q1 Results and Dividend for Pee Cee Cosma Sope

🟡 NEUTRAL ⭐ 3/10

BOARD_MEETING 📅 04 Aug 2026, 04:31 PM

Pee Cee Cosma Sope Ltd has scheduled a board meeting on August 12, 2026, to review and approve the unaudited financial results for the quarter ended June 30, 2026. The board will also finalize the date for the Annual General Meeting (AGM) and determine the book closure dates for dividend payments. The company currently holds a market capitalization of ₹93 Cr and reported a TTM revenue of ₹158 Cr with a debt-free status. Investors will be monitoring for a recovery in profitability after the March 2026 quarter saw a sharp decline in net profit to ₹0.84 Cr from ₹3.05 Cr in the prior quarter.